Dr. Luo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-5301Fax+1 617-632-5786
Education & Training
- Oregon Health & Science University (OHSU Health)Chief Residency, Internal Medicine, 2017 - 2018
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2014 - 2017
- Stanford University School of MedicineClass of 2014, MD
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- FL State Medical License 2023 - Present
- MA State Medical License 2021 - 2026
- OR State Medical License 2017 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States Start of enrollment: 2020 Jun 21
Publications & Presentations
PubMed
- Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck.Jia Luo, Justin A Bishop, Steven G DuBois, Glenn J Hanna, Lynette M Sholl
Nature Reviews. Clinical Oncology. 2025-02-03 - Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis Carcinoma.Gianna Kroening, Jia Luo, Mark G Evans, Tolulope Adeyelu, Sai-Hong Ignatius Ou
JCO Precision Oncology. 2024-10-01 - Tackling KRAS-mutated non-small-cell lung cancer: iteration and exploration.Jia Luo, Liza C Villaruz
The Lancet. Respiratory Medicine. 2024-08-01
Journal Articles
- Role of p38γ MAPK in Regulation of EMT and Cancer Stem CellsJia Luo, MD, ScienceDirect
Press Mentions
- Lung Adenocarcinoma with Mucinous HistologyDecember 16th, 2024
- KRAS-Mutant NSCLC: Has the 'Undruggable' Cancer Finally Met Its Match?June 10th, 2022
- For High-Risk Cancer Patients, Experts Consider Any Vaccine-Induced Covid-19 Protection BeneficialMarch 9th, 2021
- Join now to see all
Professional Memberships
- Member
External Links
- LinkedInhttps://www.linkedin.com/in/jluo1
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: